tapebrief

MO · Q2 2025 Earnings

Cautious

Altria

Reported July 30, 2025

30-second summary

Altria narrowed FY25 adjusted EPS guidance to $5.35–$5.45 (3–5% growth off the $5.19 2024 base), with Q2 non-GAAP EPS of $1.44 and revenue of $6.10B (-1.7% YoY). The headline is that cigarette volumes fell 10.2% yet smokeable adjusted OCI margin held at 64.5% — pricing and mix did the work again. The subtler signal: management explicitly flagged H2 EPS growth will "moderate" as the 2024 ASR and MSA legal fund benefits roll off, and tied multiple forward narratives (Enjoy re-entry, volume stabilization) to illicit-vape enforcement that they themselves called "too soon to call a trend."

Headline numbers

EPS

Q2 FY2025

$1.44

Revenue

Q2 FY2025

$6.10B

-1.7% YoY

Gross margin

Q2 FY2025

63.0%

Operating margin

Q2 FY2025

52.9%

Key financials

Q2 FY2025
MetricQ2 FY2025YoY
Revenue$6.10B-1.7%
EPS$1.44
Gross margin63.0%
Operating margin52.9%

Guidance

Prior quarter data unavailable — comparison not possible.

Segment performance

Q2 FY2025
SegmentQ2 FY2025YoY
Smokeable Products$5.357B-2.5%
Oral Tobacco Products$0.753B+5.9%

Platform metrics

Q2 FY2025
SegmentQ2 FY2025
Smokeable Products Domestic Cigarette Shipment Volume Change-10.2%
Marlboro Retail Share of Total Cigarette Category41.0%
on! Oral Nicotine Pouch Category Share8.7%
Oral Tobacco Products Segment Retail Share33.1%

Profitability

Q2 FY2025
SegmentQ2 FY2025
Adjusted Operating Companies Income Margin - Smokeable Products64.5%
Adjusted Operating Companies Income Margin - Oral Tobacco Products68.7%

Other KPIs

Q2 FY2025
SegmentQ2 FY2025
Share Repurchases$274 million
Dividend Payments$1.7 billion

Management tone

This is first coverage, so no multi-quarter narrative arc is drawn yet. The shifts below come from this quarter's call relative to management's prior public posture.

The Enjoy re-entry framing moved from a product-readiness question to a market-conditions question. Where prior commentary tied Enjoy's return to PTAB resolution, the language this quarter was: "When you see that state of play, remember, disposables are increasing. That means that pod-based products are decreasing...certainly when we bring it back to market, we're going to be disciplined about it." That is management telling investors not to model an Enjoy contribution on a specific timeline — the gating factor is now the illicit-disposable cleanup, which is outside Altria's control.

The cigarette volume narrative shifted from secular decline to partially enforcement-driven stabilization. Management noted volumes "have improved a bit" over the last two months and attributed the decomp to both macro and cross-category dynamics — meaning some smokers are coming back from illicit disposables. Useful tailwind, but it's borrowed: if enforcement loosens, the volume help reverses. Hence the heavy use of "I think it's too soon to call it a trend one way or the other...we need consistent action."

The EPS algorithm got a quiet downshift for H2. The explicit phrasing — "We expect EPS growth to moderate as we lap the lower share count associated with the 2024 accelerated share repurchase program and the benefit of the MSA legal fund expiration" — concedes that the back half won't carry the same growth optics as the first half, even as FY guidance was narrowed at the high end. Investors who anchored on H1 run-rate will mis-model H2.

OAN's competitive framing changed materially. Prior calls positioned on! as a clean share-gain story; this quarter it's an "increasingly competitive environment" where Helix grows but MST declines aren't fully offset. That's a different unit economics conversation — share gains in a fragmenting pouch market are harder to monetize than share gains in a consolidating one.

Across the call, hedging language was unusually dense: "remains to be seen," "remains an unknown variable," "I can't satisfy you with an exact date," "more to share in the future." That cluster of phrasing, paired with a guidance narrowing rather than a raise, is the dominant signal.

Recurring themes management leaned on this quarter:

Illicit vape enforcement momentum but long-term sustainability uncertainConsumer economic strain persisting despite some 'green shoots'OAN growth strong but facing increased competition in nicotine pouch categoryEnjoy re-entry timing now market-condition dependent rather than product-readyCigarette volume stabilization from mix of enforcement and consumer behavior shiftsDisciplined capital allocation balancing shareholder returns with NGP investments

Risks management surfaced:

Macroeconomic uncertainty and continued inflation pressuring low-income tobacco consumersTrade negotiations and tariffs creating unknown impact on consumer spendingMisdeclaration of illicit vape shipments circumventing border enforcementDisposable e-vapor market still growing despite enforcement, cannibalizing pod-based productsPatent litigation on Enjoy not resolved; PTAB ruled against Altria's invalidation argument

Q&A highlights

Emma Rumney · Reuters

What specific parts of the business are affected by increased tariffs and in which countries? Also, are tariffs affecting packaging for cigarettes, oral tobacco, or both?

Tariffs have been contemplated in guidance but are not viewed as material to overall business. Impact is primarily in supply chain and direct materials like packaging (foil liners, tin cans) for some overseas/international sourcing. No material cost impact warranting price increases or supply chain changes. Management has flexibility across supply chain with different vendors and geographies to manage tariff impacts.

Tariffs not material to overall businessImpact on packaging materials (foil liners, tin cans)Supply chain is overseas/internationally based for some materialsMultiple vendor optionality across geographies

What to watch into next quarter

H2 EPS cadence vs. the "moderation" warning. Q3 non-GAAP EPS needs to clear roughly $1.40 to leave Q4 reasonable inside the $5.35–$5.45 band; anything materially below puts the low end at risk.

Cigarette shipment volume decline trajectory. Q2 was -10.2%. If Q3 narrows to high-single-digits, the enforcement tailwind is real; if it widens back past -11%, the "two months of improvement" was noise.

Oral Tobacco segment retail share direction from 33.1%. Whether OAN gains can again outrun MST declines is the cleanest single read on whether smoke-free transition economics are intact.

Any Q3 commentary that puts a date — even a quarter — on Enjoy re-entry. Continued deferral to "market conditions" language signals 2026 at the earliest.

on! category share movement from 8.7%. Flat or declining sequential share in a still-growing pouch category would confirm the "increasingly competitive" framing has teeth.

Whether ACE returns to market in 2025. Guidance explicitly assumes it does not; any change is a direct guidance risk.

Sources

  1. Altria Q2 2025 Earnings Press Release (Exhibit 99.1), SEC filing: https://www.sec.gov/Archives/edgar/data/764180/000076418025000109/exhibit991erq22025.htm

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.